MSD (Merck Sharp & Dohme)

Type
Business expansion
Country
Czechia
Region
Česko; Praha; Hlavní město Praha
Location of affected unit(s)
Prague
Sector
Information / Computing
63 - Computing infrastructure, data processing, hosting and other information service activities
63 - Computing infrastructure, data processing, hosting and other information service activities
63 - Computing infrastructure, data processing, hosting and other information service activities
100 jobs
Number of planned job creations
Job creation
Announcement Date
23 April 2014
Employment effect (start)
24 April 2014
Foreseen end date
31 December 2014

Description

US-based pharmaceutical company MSD (Merck Sharp & Dohme) is to open a global IT centre in Prague and to create 100 new jobs in 2014. As reported, with investments exceeding CZK 1 billion during the first three years of the operation, the company plans to create in total 200 new jobs by the end of 2015.

MSD has been operating in the Czech Republic since 1992. The company focuses on biological therapy, vaccines, treatment of diabetes and other diseases.

In October 2013, the pharmaceutical group Merck announced a global job reduction restructuring plan.

Sources

  • 24 April 2014: Cijjournal
  • 23 April 2014: Zpravy

Citation

Eurofound (2014), MSD (Merck Sharp & Dohme), Business expansion in Czechia, factsheet number 76902, European Restructuring Monitor. Dublin, https://apps.eurofound.europa.eu/restructuring-events/detail/76902.